Mutations in EGFR, resulting in greater affinity for ATP binding by the EGFR tyrosine kinase domain and constitutive activation, are found in ~15% of lung cancers in Caucasians and 40% in Asians (5, 6). Here, EGFR is linked to lung cancer.